Provided by Tiger Fintech (Singapore) Pte. Ltd.

Psyence Biomedical Ltd

0.6990
+0.00801.16%
Volume:61.53K
Turnover:42.69K
Market Cap:3.16M
PE:0.00
High:0.7115
Open:0.6910
Low:0.6706
Close:0.6910
Loading ...

Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase Iib Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care

THOMSON REUTERS
·
24 Oct 2024

Psyence Biomedical Ltd - Biomed to Announce Topline Data in H2 2025

THOMSON REUTERS
·
24 Oct 2024

Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care

GlobeNewswire
·
24 Oct 2024

Inside CVS and Walgreens’ downturn: How misguided M&A damaged America’s drugstores

Fortune
·
24 Oct 2024

Psyence Biomedical Plans Key Shareholder Meeting

TIPRANKS
·
24 Oct 2024

CVS Stock Plummets as It Replaces CEO

Investopedia
·
18 Oct 2024

BRIEF-Psyence Biomedical Says Confident That PsyLabs Is On Track To Produce GMP Certified, Nature-Derived Psychedelic APIs

Reuters
·
17 Oct 2024

Psyence Biomed Provides Progress Update on Psylabs E.u. Good Manufacturing Practices (Gmp) Certified Active Pharmaceutical Ingredient (API) Development

THOMSON REUTERS
·
17 Oct 2024

Psyence Biomedical Ltd: Confident Is on Track to Produce Gmp Certified, Nature-Derived Psychedelic Apis

THOMSON REUTERS
·
17 Oct 2024

Press Release: Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development

Dow Jones
·
17 Oct 2024

BRIEF-Psyence Group Enters Into Debt-For-Equity Swap Agreement With Its Nasdaq-Listed Associate, Psyence Biomedical

Reuters
·
14 Oct 2024

Psyence Group Inc - Psyence Biomed to Issue 2.8 Mln Shares at $0.50 Each

THOMSON REUTERS
·
14 Oct 2024

Psyence Group Enters Into Debt-for-Equity Swap Agreement With Its Nasdaq-Listed Associate, Psyence Biomedical

THOMSON REUTERS
·
14 Oct 2024

Is Elevance Health (ELV) a Top Healthcare Stock to Buy Now?

Insider Monkey
·
14 Oct 2024

Walgreens Boots Alliance: Buy Rating Affirmed Despite Adjusted EPS Estimates, with Positive Outlook on Store Optimization and PBM Negotiations

TIPRANKS
·
11 Oct 2024

Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?

Motley Fool
·
05 Oct 2024